About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 854846, 8 pages
http://dx.doi.org/10.1155/2012/854846
Review Article

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation

1Center for Vascularized Composite Allotransplantation, Kaohsiung Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Kaohsiung 833, Taiwan
2Department of Plastic and Reconstructive Surgery, Kaohsiung Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Kaohsiung 833, Taiwan
3Liver Transplantation Program and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Kaohsiung 833, Taiwan

Received 29 June 2012; Revised 22 September 2012; Accepted 23 September 2012

Academic Editor: Gerald Brandacher

Copyright © 2012 Yur-Ren Kuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. P. A. Lee, “Composite tissue transplantation: more science and patience needed,” Plastic and Reconstructive Surgery, vol. 107, no. 4, pp. 1066–1070, 2001. View at Scopus
  2. J. M. Dubernard and B. Devauchelle, “Face transplantation,” The Lancet, vol. 372, no. 9639, pp. 603–604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Jones, S. A. Gruber, J. H. Barker, and W. C. Breidenbach, “Successful hand transplantation: one-year follow-up,” The New England Journal of Medicine, vol. 343, no. 7, pp. 468–473, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Kaufman and W. Breidenbach, “World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program,” Hand Clinics, vol. 27, no. 4, pp. 417–421, 2011.
  5. M. Siemionow and C. Ozturk, “An update on facial transplantation cases performed between 2005 and 2010,” Plastic and Reconstructive Surgery, vol. 128, pp. 707e–720e, 2011.
  6. J. T. Shores, J. E. Imbriglia, and W. P. Lee, “The current state of hand transplantation,” American Journal of Hand Surgery, vol. 36, pp. 1862–1867, 2011.
  7. W. P. A. Lee, M. J. Yaremchuk, Y. C. Pan, M. A. Randolph, C. M. Tan, and A. J. Weiland, “Relative antigenicity of components of a vascularized limb allograft,” Plastic and Reconstructive Surgery, vol. 87, no. 3, pp. 401–411, 1991. View at Scopus
  8. H. Madani, S. Hettiaratchy, A. Clarke, and P. E. M. Butler, “Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 61, no. 3, pp. 245–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Schneeberger, V. S. Gorantla, R. P. van Riet et al., “Atypical acute rejection after hand transplantation,” American Journal of Transplantation, vol. 8, no. 3, pp. 688–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. L. Kaufman, R. Ouseph, B. Blair, et al., “Graft vasculopathy in clinical hand transplantation,” American Journal of Transplantation, vol. 12, no. 4, pp. 1004–1016, 2012.
  11. K. Ravindra, M. Haeberle, L. S. Levin, and S. T. Ildstad, “Immunology of vascularized composite allotransplantation: a primer for hand surgeons,” American Journal of Hand Surgery, vol. 37, no. 4, pp. 842–850, 2012.
  12. N. Arima, F. Nakamura, A. Fukunaga et al., “Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study,” Cytotherapy, vol. 12, no. 2, pp. 265–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Bacigalupo, “Management of acute graft-versus-host disease,” British Journal of Haematology, vol. 137, no. 2, pp. 87–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. W. Dryden Jr., “Overview of biologic therapy for Crohn's disease,” Expert Opinion on Biological Therapy, vol. 9, no. 8, pp. 967–974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Dalal, K. Gandy, and J. Domen, “Role of mesenchymal stem cell therapy in Crohn's disease,” Pediatric Research, vol. 71, no. 4, pp. 445–451, 2012.
  16. G. Lanzoni, G. Roda, A. Belluzi, E. Roda, and G. P. Bagnara, “Inflammatory bowel disease: moving toward a stem cell-based therapy,” World Journal of Gastroenterology, vol. 14, no. 29, pp. 4616–4626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Connick, M. Kolappan, C. Crawley, et al., “Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study,” The Lancet Neurology, vol. 11, no. 2, pp. 150–156, 2012.
  18. D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky et al., “Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis,” Archives of Neurology, vol. 67, no. 10, pp. 1187–1194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Liang, H. Zhang, B. Hua, et al., “Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study,” Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1423–1429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Shi, D. Wang, X. Li, et al., “Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus,” Clinical Rheumatology, vol. 31, no. 5, pp. 841–846, 2012.
  21. A. J. Friedenstein, U. F. Gorskaja, and N. N. Kulagina, “Fibroblast precursors in normal and irradiated mouse hematopoietic organs,” Experimental Hematology, vol. 4, no. 5, pp. 267–274, 1976. View at Scopus
  22. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. R. Kuo, C. T. Wang, J. T. Cheng, F. S. Wang, Y. C. Chiang, and C. J. Wang, “Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes,” Plastic and Reconstructive Surgery, vol. 128, no. 4, pp. 872–880, 2011.
  24. M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991. View at Scopus
  26. P. S. In't Anker, S. A. Scherjon, C. Kleijburg-van der Keur et al., “Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta,” Stem Cells, vol. 22, no. 7, pp. 1338–1345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Bieback, S. Kern, H. Klüter, and H. Eichler, “Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood,” Stem Cells, vol. 22, no. 4, pp. 625–634, 2004. View at Scopus
  28. P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Deans and A. B. Moseley, “Mesenchymal stem cells: biology and potential clinical uses,” Experimental Hematology, vol. 28, no. 8, pp. 875–884, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Krampera, S. Glennie, J. Dyson et al., “Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide,” Blood, vol. 101, no. 9, pp. 3722–3729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Glennie, I. Soeiro, P. J. Dyson, E. W. F. Lam, and F. Dazzi, “Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells,” Blood, vol. 105, no. 7, pp. 2821–2827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Rasmusson, O. Ringdén, B. Sundberg, and K. Le Blanc, “Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells,” Transplantation, vol. 76, no. 8, pp. 1208–1213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. R. Kuo, C. C. Chen, S. Goto, et al., “Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model,” Plastic and Reconstructive Surgery, vol. 128, no. 6, pp. 661e–672e, 2011.
  35. Y. R. Kuo, C. C. Chen, H. S. Shih et al., “Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model,” Plastic and Reconstructive Surgery, vol. 127, no. 2, pp. 569–579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. J. Coffer and B. M. T. Burgering, “Forkhead-box transcription factors and their role in the immune system,” Nature Reviews Immunology, vol. 4, no. 11, pp. 889–899, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. H. von Boehmer, “Mechanisms of suppression by suppressor T cells,” Nature Immunology, vol. 6, no. 4, pp. 338–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Fehérvári and S. Sakaguchi, “Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells,” International Immunology, vol. 16, no. 12, pp. 1769–1780, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Nauta and W. E. Fibbe, “Immunomodulatory properties of mesenchymal stromal cells,” Blood, vol. 110, no. 10, pp. 3499–3506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., “Mesenchymal stem cells: mechanisms of immunomodulation and homing,” Cell Transplantation, vol. 19, no. 6-7, pp. 667–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. H. Kim, Y. M. Wee, M. Y. Choi, D. G. Lim, S. C. Kim, and D. J. Han, “Interleukin (IL)-10 induced by CD11b+ cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts,” Molecular Medicine, vol. 17, no. 7-8, pp. 697–708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, “Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells,” Clinical and Experimental Immunology, vol. 156, no. 1, pp. 149–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. U. Hainz, B. Jürgens, and A. Heitger, “The role of indoleamine 2,3-dioxygenase in transplantation,” Transplant International, vol. 20, no. 2, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo, “Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation,” Blood, vol. 103, no. 12, pp. 4619–4621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Maccario, A. Moretta, A. Cometa et al., “Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes,” Biology of Blood and Marrow Transplantation, vol. 11, no. 12, pp. 1031–1032, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Beyth, Z. Borovsky, D. Mevorach et al., “Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness,” Blood, vol. 105, no. 5, pp. 2214–2219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. A. W. Thomson, “Tolerogenic dendritic cells: all present and correct?” American Journal of Transplantation, vol. 10, no. 2, pp. 214–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. P. T. H. Coates, B. L. Colvin, K. Kaneko, T. Taner, and A. W. Thomson, “Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity,” Transplantation, vol. 75, no. 9, supplement, pp. 32S–36S, 2003. View at Scopus
  51. Y. J. Jung, S. Y. Ju, E. S. Yoo et al., “MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC,” Cytotherapy, vol. 9, no. 5, pp. 451–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. P. A. Morel, M. Feili-Hariri, P. T. Coates, and A. W. Thomson, “Dendritic cells, T cell tolerance and therapy of adverse immune reactions,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 1–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. R. Kuo, C. W. Huang, S. Goto et al., “Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation,” Journal of Surgical Research, vol. 153, no. 2, pp. 317–325, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. W. E. Fibbe, A. J. Nauta, and H. Roelofs, “Modulation of immune responses by mesenchymal stem cells,” Annals of the New York Academy of Sciences, vol. 1106, pp. 272–278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. X. X. Jiang, Y. Zhang, B. Liu et al., “Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells,” Blood, vol. 105, no. 10, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Yañez, M. L. Lamana, J. García-Castro, I. Colmenero, M. Ramírez, and J. A. Bueren, “Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease,” Stem Cells, vol. 24, no. 11, pp. 2582–2591, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. O. Ringdén, M. Uzunel, I. Rasmusson et al., “Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease,” Transplantation, vol. 81, no. 10, pp. 1390–1397, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. K. English, A. French, and K. J. Wood, “Mesenchymal stromal cells: facilitators of successful transplantation?” Cell Stem Cell, vol. 7, no. 4, pp. 431–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Bartholomew, C. Sturgeon, M. Siatskas et al., “Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo,” Experimental Hematology, vol. 30, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Sbano, A. Cuccia, B. Mazzanti et al., “Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model,” Archives of Dermatological Research, vol. 300, no. 3, pp. 115–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Pan, K. Zhao, L. Wang et al., “Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation,” Journal of Surgical Research, vol. 160, no. 2, pp. 315–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. R. Kuo, J. M. Sacks, W. P. A. Lee et al., “Porcine heterotopic composite tissue allograft transplantation using a large animal model for preclinical studies,” Chang Gung Medical Journal, vol. 29, no. 3, pp. 268–274, 2006. View at Scopus
  63. Y. R. Kuo, S. Goto, H. S. Shih et al., “Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model,” Transplantation, vol. 87, no. 12, pp. 1769–1777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Casiraghi, N. Azzollini, P. Cassis et al., “Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells,” The Journal of Immunology, vol. 181, no. 6, pp. 3933–3946, 2008. View at Scopus
  65. S. Itakura, S. Asari, J. Rawson et al., “Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat,” American Journal of Transplantation, vol. 7, no. 2, pp. 336–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. R. Kuo, C. C. Chen, S. Goto, et al., “Immunomodulatory effects of bone marrow-derived mesenchymal stem cells in a Swine hemi-facial allotransplantation model,” PLoS One, vol. 7, no. 4, Article ID e35459, 2012.
  67. W. Ge, J. Jiang, M. L. Baroja, et al., “Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance,” American Journal of Transplantation, vol. 9, no. 8, pp. 1760–1772, 2009.
  68. Y. R. Kuo, H. S. Shih, C. C. Lin et al., “Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection,” Journal of Surgical Research, vol. 153, no. 2, pp. 268–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Prevosto, M. Zancolli, P. Canevali, M. R. Zocchi, and A. Poggi, “Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction,” Haematologica, vol. 92, no. 7, pp. 881–888, 2007. View at Publisher · View at Google Scholar · View at Scopus